These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24708385)

  • 21. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.
    Minke JM; Siger L; Karaca K; Austgen L; Gordy P; Bowen R; Renshaw RW; Loosmore S; Audonnet JC; Nordgren B
    Arch Virol Suppl; 2004; (18):221-30. PubMed ID: 15119777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).
    Jarvi SI; Lieberman MM; Hofmeister E; Nerurkar VR; Wong T; Weeks-Levy C
    Vaccine; 2008 Oct; 26(42):5338-44. PubMed ID: 18723064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.
    Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R
    Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys.
    Muraki Y; Fujita T; Matsuura M; Fuke I; Manabe S; Ishikawa T; Okuno Y; Morita K
    Virol J; 2015 Apr; 12():54. PubMed ID: 25889682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine.
    Quintel BK; Thomas A; Poer DeRaad DE; Slifka MK; Amanna IJ
    Vaccine; 2019 Jul; 37(30):4214-4221. PubMed ID: 30606462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccination of the American crow (Corvus brachyrhynchos) provides partial protection against lethal challenge with West Nile virus.
    Bunning ML; Fox PE; Bowen RA; Komar N; Chang GJ; Speaker TJ; Stephens MR; Nemeth N; Panella NA; Langevin SA; Gordy P; Teehee M; Bright PR; Turell MJ
    Avian Dis; 2007 Jun; 51(2):573-7. PubMed ID: 17626486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses.
    Siger L; Bowen RA; Karaca K; Murray MJ; Gordy PW; Loosmore SM; Audonnet JC; Nordgren RM; Minke JM
    Am J Vet Res; 2004 Nov; 65(11):1459-62. PubMed ID: 15566080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
    Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASSESSING THE HUMORAL RESPONSE TO AND SAFETY OF A COMMERCIALLY AVAILABLE EQUINE WEST NILE VIRUS VACCINE IN A ZOO-BASED CONSERVATION BREEDING POPULATION OF ENDANGERED GREATER SAGE-GROUSE (
    Vaasjo E; Black SR; Pastor A; Whiteside DP
    J Zoo Wildl Med; 2021 Jun; 52(2):732-736. PubMed ID: 34130419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.
    Pinto AK; Richner JM; Poore EA; Patil PP; Amanna IJ; Slifka MK; Diamond MS
    J Virol; 2013 Feb; 87(4):1926-36. PubMed ID: 23221549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of neutralizing antibodies to West Nile virus in Eleonora's Falcons in the Canary Islands.
    Gangoso L; Grande JM; Llorente F; Jiménez-Clavero MÁ; Pérez JM; Figuerola J
    J Wildl Dis; 2010 Oct; 46(4):1321-4. PubMed ID: 20966288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection.
    Chang GJ; Davis BS; Stringfield C; Lutz C
    Vaccine; 2007 Mar; 25(12):2325-30. PubMed ID: 17224209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area.
    Fehér O; Bakonyi T; Barna M; Nagy A; Takács M; Szenci O; Joó K; Sárdi S; Korbacska-Kutasi O
    Vet Immunol Immunopathol; 2020 Sep; 227():110087. PubMed ID: 32629300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-structural protein 1 (NS1) antibody-based assays to differentiate West Nile (WN) virus from Japanese encephalitis virus infections in horses: effects of WN virus NS1 antibodies induced by inactivated WN vaccine.
    Kitai Y; Kondo T; Konishi E
    J Virol Methods; 2011 Jan; 171(1):123-8. PubMed ID: 20974180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. West Nile virus vaccines.
    Hall RA; Khromykh AA
    Expert Opin Biol Ther; 2004 Aug; 4(8):1295-305. PubMed ID: 15268663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equine vaccine for West Nile virus.
    Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
    Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine.
    Poore EA; Slifka DK; Raué HP; Thomas A; Hammarlund E; Quintel BK; Torrey LL; Slifka AM; Richner JM; Dubois ME; Johnson LP; Diamond MS; Slifka MK; Amanna IJ
    Vaccine; 2017 Jan; 35(2):283-292. PubMed ID: 27919629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination of mice using the West Nile virus E-protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects mice against a lethal challenge.
    De Filette M; Soehle S; Ulbert S; Richner J; Diamond MS; Sinigaglia A; Barzon L; Roels S; Lisziewicz J; Lorincz O; Sanders NN
    PLoS One; 2014; 9(2):e87837. PubMed ID: 24503579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avian titer development against West nile virus after extralabel use of an equine vaccine.
    Johnson S
    J Zoo Wildl Med; 2005 Jun; 36(2):257-64. PubMed ID: 17323567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.